Prostaglandin E 2 induced contraction of human intercostal arteries is mediated by the EP 3 receptor

European Journal of Pharmacology

Volumn 681, Issue 1-3, 2012, Pages 55-59

  Longrois, Dan ^a   Gomez, Ingrid ^a,b   Foudi, Nabil ^c   Topal, Gokce ^d   Dhaouadi, Malek ^a   Kotelevets, Larissa ^e   Chastre, Eric ^e   Norel, Xavier ^a,b  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c FERHAT ABBAS UNIVERSITY   (Algeria)

^d ISTANBUL UNIVERSITY   (Turkey)

^e CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

EP 1; EP 3; Human collateral aorta; Prostaglandin E 2; Vasoconstriction

Indexed keywords

MESSENGER RNA; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2;

ARTERY; ARTERY BLOOD FLOW; ARTERY CONSTRICTION; ARTICLE; BIOACCUMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE FUNCTION; HUMAN; HUMAN TISSUE; INTERCOSTAL ARTERY; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROSTAGLANDIN E RECEPTOR 1 GENE; PROSTAGLANDIN E RECEPTOR 3 GENE; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RECEPTOR BLOCKING; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD BLOOD FLOW; VASCULITIS;

ARTERIES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; RNA, MESSENGER; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84858706509     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.01.041     Document Type: Article

References (30)

1. M. Abramovitz, M. Adam, Y. Boie, M. Carriere, D. Denis, C. Godbout, S. Lamontagne, C. Rochette, N. Sawyer, N.M. Tremblay, M. Belley, M. Gallant, C. Dufresne, Y. Gareau, R. Ruel, H. Juteau, M. Labelle, N. Ouimet, and K.M. Metters The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs Biochim. Biophys. Acta 1483 2000 285 293 (Pubitemid 30029060)
2. C.W. Acher, and M. Wynn A modern theory of paraplegia in the treatment of aneurysms of the thoracoabdominal aorta: an analysis of technique specific observed/expected ratios for paralysis J. Vasc. Surg. 49 2009 1117 1124 (discussion 1124)
3. S.P. Alexander, A. Mathie, and J.A. Peters Guide to receptors and channels (GRAC), 4th edition Br. J. Pharmacol. 158 Suppl. 1 2009 S1 S254
4. G. Audibert, C. Charpentier, C. Seguin-Devaux, P.A. Charretier, H. Gregoire, Y. Devaux, J.F. Perrier, D. Longrois, and P.M. Mertes Improvement of donor myocardial function after treatment of autonomic storm during brain death Transplantation 82 2006 1031 1036 (Pubitemid 44632117)
5. T. Bayston, S. Ramessur, J. Reise, K.G. Jones, and J.T. Powell Prostaglandin E2 receptors in abdominal aortic aneurysm and human aortic smooth muscle cells J. Vasc. Surg. 38 2003 354 359 (Pubitemid 41123262)
6. D. Bishop-Bailey, J.R. Pepper, S.W. Larkin, and J.A. Mitchell Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: role of endogenous prostanoids Arterioscler. Thromb. Vasc. Biol. 18 1998 1655 1661 (Pubitemid 28465420)
7. N. Boccheciampe, G. Audibert, O. Rangeard, C. Charpentier, J.F. Perrier, J.M. Lalot, C. Voltz, P. Strub, C. Loos-Ayav, C. Meistelman, P.M. Mertes, and D. Longrois Serum troponin Ic values in organ donors are related to donor myocardial dysfunction but not to graft dysfunction or rejection in the recipients Int. J. Cardiol. 133 2009 80 86
8. A. Chaikhouni, F.A. Crawford, P.J. Kochel, L.S. Olanoff, and P.V. Halushka Human internal mammary artery produces more prostacyclin than saphenous vein J. Thorac. Cardiovasc. Surg. 92 1986 88 91 (Pubitemid 16096084)
9. F. Cipollone, M. Fazia, A. Iezzi, M. Zucchelli, B. Pini, D. De Cesare, S. Ucchino, F. Spigonardo, G. Bajocchi, R. Bei, R. Muraro, L. Artese, A. Piattelli, F. Chiarelli, F. Cuccurullo, and A. Mezzetti Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans Circulation 107 2003 1479 1485 (Pubitemid 36378484)
10. C.D. Etz, S. Zoli, M.S. Bischoff, C. Bodian, G. Di Luozzo, and R.B. Griepp Measuring the collateral network pressure to minimize paraplegia risk in thoracoabdominal aneurysm resection J. Thorac. Cardiovasc. Surg. 140 2010 S125 S130 (discussion S142-S146)
11. N. Foudi, L. Kotelevets, L. Louedec, G. Leseche, D. Henin, E. Chastre, and X. Norel Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype Br. J. Pharmacol. 154 2008 1631 1639
12. N. Foudi, L. Louedec, T. Cachina, C. Brink, and X. Norel Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation Cardiovasc. Res. 81 2009 269 277
13. N. Foudi, L. Kotelevets, I. Gomez, L. Louedec, D. Longrois, E. Chastre, and X. Norel Differential reactivity of human mammary artery and saphenous vein to prostaglandin E(2): implication for cardiovascular grafts Br. J. Pharmacol. 163 2011 826 834
14. G.W. He Arterial grafts for coronary artery bypass grafting: biological characteristics, functional classification, and clinical choice Ann. Thorac. Surg. 67 1999 277 284
15. L.F. Hiratzka, G.L. Bakris, J.A. Beckman, R.M. Bersin, V.F. Carr, D.E. Casey Jr., K.A. Eagle, L.K. Hermann, E.M. Isselbacher, E.A. Kazerooni, N.T. Kouchoukos, B.W. Lytle, D.M. Milewicz, D.L. Reich, S. Sen, J.A. Shinn, L.G. Svensson, and D.M. Williams 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine Circulation 121 2010 e266 e369
16. H. Jiang, A.S. Weyrich, G.A. Zimmerman, and T.M. McIntyre Endothelial cell confluence regulates cyclooxygenase-2 and prostaglandin E2 production that modulate motility J. Biol. Chem. 279 2004 55905 55913 (Pubitemid 40066598)
17. R.L. Jones, D.F. Woodward, J.W. Wang, and R.L. Clark Roles of affinity and lipophilicity in the slow kinetics of prostanoid receptor antagonists on isolated smooth muscle preparations Br. J. Pharmacol. 162 2011 863 879
18. N. Kawaharada, T. Ito, T. Koyanagi, R. Harada, H. Hyodoh, Y. Kurimoto, A. Watanabe, and T. Higami Spinal cord protection with selective spinal perfusion during descending thoracic and thoracoabdominal aortic surgery Interact. Cardiovasc. Thorac. Surg. 10 2010 986 990 (discussion 990-981)
19. T. Maruyama, and S. Ohuchida Selective agonists and antagonists for prostaglandin E2 receptor subtypes Tanpakushitsu Kakusan Koso 45 2000 1001 1007
20. X. Norel Prostanoid receptors in the human vascular wall Sci. World J. 7 2007 1359 1374 (Pubitemid 47435435)
21. X. Norel, V. de Montpreville, and C. Brink Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713 Prostaglandins Other Lipid Mediat. 74 2004 101 112 (Pubitemid 39360223)
22. D. Proudfoot, C. Fitzsimmons, J. Torzewski, and D.E. Bowyer Inhibition of human arterial smooth muscle cell growth by human monocyte/macrophages: a co-culture study Atherosclerosis 145 1999 157 165 (Pubitemid 29292711)
23. Y.M. Qian, R.L. Jones, K.M. Chan, A.I. Stock, and J.K. Ho Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery Br. J. Pharmacol. 113 1994 369 374 (Pubitemid 24310729)
24. O. Rangeard, G. Audibert, J.F. Perrier, C. Loos-Ayav, J.M. Lalot, M. Agavriloaie, C. Meistelman, H. Gregoire, P.M. Mertes, and D. Longrois Relationship between procalcitonin values and infection in brain-dead organ donors Transplant. Proc. 39 2007 2970 2974 (Pubitemid 350251411)
25. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, T.M. Brown, M.R. Carnethon, S. Dai, G. de Simone, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, K.J. Greenlund, S.M. Hailpern, J.A. Heit, P.M. Ho, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, M.M. McDermott, J.B. Meigs, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, W.D. Rosamond, P.D. Sorlie, R.S. Stafford, T.N. Turan, M.B. Turner, N.D. Wong, and J. Wylie-Rosett Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
26. U. Schonbeck, G.K. Sukhova, P. Graber, S. Coulter, and P. Libby Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions Am. J. Pathol. 155 1999 1281 1291 (Pubitemid 29488935)
27. M. Sussmann, M. Sarbia, J. Meyer-Kirchrath, R.M. Nusing, K. Schror, and J.W. Fischer Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins Circ. Res. 94 2004 592 600 (Pubitemid 38387741)
28. T. Suzawa, C. Miyaura, M. Inada, T. Maruyama, Y. Sugimoto, F. Ushikubi, A. Ichikawa, S. Narumiya, and T. Suda The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs Endocrinology 141 2000 1554 1559 (Pubitemid 32269125)
29. K. Takayama, G. Garcia-Cardena, G.K. Sukhova, J. Comander, M.A. Gimbrone Jr., and P. Libby Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor J. Biol. Chem. 277 2002 44147 44154 (Pubitemid 36157844)
30. L. Walch, V. de Montpreville, C. Brink, and X. Norel Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins Br. J. Pharmacol. 134 2001 1671 1678 (Pubitemid 34038100)